INTRODUCTION
One of the great draw backs in hormonal treatment of metastasized mammary carcinoma is the lack of sufficient objective standards. The importance of diagnostic criteria is not only related with the choice of the most efficient therapy, but also with the sometimes tumour-stimulating effect of hormonal substances. In patients with skeletal metastases the calcium excretion in the urine may be one of these objective standards, as has been shown already by Laszlo et al. (1952) and Pearson et al. (1952) . The 2. The relationship between the calcium content of the serum and the cal¬ cium excretion in the daily urine of these patients and the influence of some factors on this relationship.
.3. The relationship between the course of the calciuria and the clinical results during hormonal treatment.
METHODS
The calcium content in serum and urine has been determined by a direct microtitration with £thylene-Z)iamine-Tetra-ylcetate using murexide as indicator (N. J. Poulie, 1954 , L. A. de Vries, 1955 (Fig. 4) Fig. 3 ) the dangerous potentialities of androgens in patients with metastasized mammary carcinoma.
Mrs. C, 58 years, with mammary carcinoma and extensive osteolytic métastases was comatose because of cerebral métastases (ascertained later at the post-mortem); she also had a hypercalciuria (Fig. 6) (Fig. 7) . However, patient gradually deteriorated and died after a few months. The urinary-calcium excretion never fell to a normal or subnormal level.
Mrs. E., 58 years, with mammary carcinoma and osteolytic métastases received testosterone-propionate when she left the hospital (Fig. 8) 
